[Form 4] LABCORP HOLDINGS INC. Insider Trading Activity

Rhea-AI Filing Summary

Labcorp (LH) reported an insider equity update by EVP, CIO & CTO Akinbolade Oyegunwa. On 11/01/2025, 370 shares of common stock were acquired via the conversion of Restricted Stock Units (code M). On 11/03/2025, 107 shares were withheld to cover taxes at $257.84 per share (code F). Following these transactions, direct holdings are 3,727.253 shares.

The filing notes 1,939 Restricted Stock Units remain outstanding. These RSUs vest in three equal annual installments beginning on November 1, 2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Oyegunwa Akinbolade

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CIO & CTO

3. Date of Earliest Transaction (Month/Day/Year)
11/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/01/2025		M		370	A	(1)	3,834.253	D
Common Stock	11/03/2025		F(2)		107	D	$257.84	3,727.253	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	11/01/2025		M			370	(3)	(3)	Common Stock	370	$0	1,939(4)	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

2. Stock withholding to satisfy tax withholding obligations.

3. The Restricted Stock Units vest in three equal annual installments beginning on November 1, 2025.

4. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

	/s/ Sandra D. van der Vaart, Attorney-in-Fact for Akinbolade Oyegunwa	11/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Labcorp (LH) report?

An officer converted 370 RSUs into common stock on 11/01/2025 and had 107 shares withheld on 11/03/2025 for taxes at $257.84 per share.

How many Labcorp (LH) shares does the insider now hold?

Directly held common stock totals 3,727.253 shares after the reported transactions.

What was the tax withholding related to the RSU conversion for LH?

A tax withholding of 107 shares occurred at $257.84 per share (code F).

How many RSUs remain outstanding for the LH officer?

The filing shows 1,939 Restricted Stock Units outstanding.

What is the vesting schedule for the reported LH RSUs?

The RSUs vest in three equal annual installments beginning on November 1, 2025.

What role does the reporting person hold at Labcorp (LH)?

The reporting person is EVP, CIO & CTO of Labcorp Holdings Inc.